This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Hims & Hers expects revenue from its weight loss business to soar in 2025, even ...
With better access to tools like CCTA and diagnostic tools that leverage CCTA, c...
Strong Customer Traction, Positive Patient Response, a Recently Granted Patent, ...
For the fourth year running, Endpoints News will highlight the biotech leaders w...
Takeda must have liked what it got from the chemoproteomics work out of BridGene...
[Sponsored] Executives from EY, Geneon, ProviderTrust, SmarterDx, and symplr sh...
Alnylam may be gearing up for its biggest commercial launch yet in its nearly 23...
It’s no great surprise that RA Capital weighed in — again — as the most ubiquito...
Eli Lilly will start selling additional single-dose vials of its weight loss dru...
The Healthcare Information and Management Systems Society (HIMSS) annual confere...
The biopharmaceutical landscape is transforming with the advent of advanced ther...
The HRT Club provides access to a network of over 700 healthcare providers who c...
An unusual legal battle over a biotech startup's IPO plans escalated to another ...
What You Should Know: – careviso, a leader in healthcare technology soluti...
What You Should Know: – QGenda, a leading provider of healthcare workforce manag...
What You Should Know: – Proximity, the intelligent automation platform maximizi...